Search Results - "Malpica, Luis E."

Adherence to infectious disease screening and immunization guidelines when treating non‐malignant immune‐mediated hematologic disorders by Malpica‐Castillo, Luis E., Palmer, Shannon, Zhu, Anqi, Deal, Allison M., Chen, Sheh‐Li, Moll, Stephan

Get full text

Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung by Wu, Susan Y., Fang, Penny Q., Fetooh, Ahmed, Manzar, Gohar S., Corrigan, Kelsey L., Schrank, Benjamin R., Nasr, Lewis, Chihara, Dai, Castillo, Luis E. Malpica, Nair, Ranjit, Steiner, Raphael E., Jain, Preetesh, Neelapu, Sattva S., Strati, Paolo, Nastoupil, Loretta J., Dabaja, Bouthaina S., Pinnix, Chelsea C., Gunther, Jillian R.

“…Definitive intent radiation therapy (RT) for early-stage mucosa-associated lymphoid tissue (MALT) lymphoma typically includes a dose of 24 to 30 Gy. While…”
Get full text

Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma by Wu, Susan Y., Fang, Penny Q., Wang, Ethan B., Ahmed, Sairah, Duvic, Madeleine, Jain, Preetesh, Castillo, Luis E. Malpica, Nair, Ranjit, Steiner, Raphael E., Strati, Paolo, Huen, Auris O., Iyer, Swaminathan P., Pinnix, Chelsea C., Dabaja, Bouthaina S., Gunther, Jillian R.

“…Purpose: Radiation therapy (RT) and the antibody-drug conjugate brentuximab vedotin (BV) are standard-of-care treatment options for patients with certain B and…”
Get full text

Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder by Wu, Susan Y, Damron, Ethan P, Xu, Jie, Fang, Penny Q, Dai, Julia, Nair, Ranjit, Malpica Castillo, Luis E, Fayad, Luis E, Torres-Cabala, Carlos A, Medeiros, L Jeffrey, Vega, Francisco, Miranda, Roberto N, Duvic, Madeleine, Pinnix, Chelsea C, Dabaja, Bouthaina S, Iyer, Swaminathan P, Huen, Auris O, Gunther, Jillian R

“…Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PCSM-LPD) is an increasingly recognized entity with heterogeneous management…”
Get full text

Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship by Medeiros, L. Jeffrey, Marques-Piubelli, Mario L., Sangiorgio, Valentina F. I., Ruiz-Cordero, Roberto, Vega, Francisco, Feldman, Andrew L., Chapman, Jennifer R., Clemens, Mark W., Hunt, Kelly K., Evans, Mark G., Khoo, Christine, Lade, Stephen, Silberman, Mark, Morkowski, Jerzy, Pina, Edward M., Mills, Daniel C., Bates, Christopher M., Magno, Winston B., Sohani, Aliyah R., Sieling, Beth A., O’Donoghue, Joseph M., Bacon, Chris M., Patani, Neill, Televantou, Despina, Turner, Suzanne D., Johnson, Laura, MacNeill, Fiona, Wotherspoon, Andrew C., Iyer, Swaminathan P., Malpica, Luis E., Patel, Keyur P., Xu, Jie, Miranda, Roberto N.

“…Breast implant anaplastic large cell lymphoma (ALCL) is a T-cell neoplasm arising around textured breast implants that was recognized recently as a distinct…”
Get full text

Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167] by Medeiros, L Jeffrey, Marques-Piubelli, Mario L, Sangiorgio, Valentina F I, Ruiz-Cordero, Roberto, Vega, Francisco, Feldman, Andrew L, Chapman, Jennifer R, Clemens, Mark W, Hunt, Kelly K, Evans, Mark G, Khoo, Christine, Lade, Stephen, Silberman, Mark, Morkowski, Jerzy, Pina, Edward M, Mills, Daniel C, Bates, Christopher M, Magno, Winston B, Sohani, Aliyah R, Sieling, Beth A, O'Donoghue, Joseph M, Bacon, Chris M, Patani, Neill, Televantou, Despina, Turner, Suzanne D, Johnson, Laura, MacNeill, Fiona, Wotherspoon, Andrew C, Iyer, Swaminathan P, Malpica, Luis E, Patel, Keyur P, Xu, Jie, Miranda, Roberto N

Get full text

Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL) by Candelaria, Myrna, Villela, Luis, Torres-Viera, Maria-Alejandra, Peña, Camila, Roa, Macarena, Zambrano, Daniela, Colunga-Pedraza, Perla R.R., Robles-Rodríguez, Arianna, Pérez-Jacobo, Fernando, Oliver, Ana Carolina, Irigoín, Maria Victoria, Baena, Rosio, Idrobo, Henry, Paredes, Sally R., Oliday, Rosa, Castro, Denisse, Montaño-Figueroa, Efeen, Perini, Guillherme F., Fernández-Aguila, Julio D., Malpica, Luis E., Beltran, Brady E., Castillo, Jorge J.

Get full text

Incidence and time course of neutropenia in patients treated with rituximab‐based therapy for non‐malignant immune‐mediated hematologic diseases by Malpica Castillo, Luis E., Palmer, Shannon, Zhu, Anqi, Deal, Allison M., Chen, Sheh‐Li, Moll, Stephan

Get full text

Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study by Riva, Eloísa, Duarte, Patricio José, Valcárcel, Bryan, Remaggi, Guillermina, Murrieta, Ivan, Corzo, Ariel, del Carpio, Daniel, Peña, Camila, Vásquez, Jule, Bove, Virginia, Teixeira, Larissa, Fleury-Perini, Guilherme, Yantorno, Sebastian, Samánez, César, Lopresti, Sergio, Altamirano, Milagros, Villela, Luis, Ruiz-Arguelles, Guillermo J., Ruiz-Delgado, Guillermo J., Montaño, Efreen, Verri, Verónica, Zamora Pérez, Elia, Pérez Jacobo, Fernando, Idrobo, Henry, Martínez-Cordero, Humberto, Beltran, Brady E., Ramírez, Jhoanna, Castillo, Jorge J., Malpica Castillo, Luis E.

“…PURPOSEWaldenstrom Macroglobulinemia (WM) is a rare lymphoma with distinct clinical features, and data from Latin American patients are lacking. Therefore, we…”
Get full text

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders by Malpica Castillo, Luis E, Palmer, Shannon, Zhu, Anqi, Deal, Allison, Chen, Sheh-Li, Moll, Stephan

“…▪ Background: The use of immunosuppressive therapies in the management of non-malignant immune-mediated hematologic disorders (NMIHD) leads to an increased…”
Get full text

Incidence and Time Course of Neutropenia in Patients Treated with Rituximab-Based Therapy for Non-Malignant Immune-Mediated Hematologic Diseases by Malpica Castillo, Luis E, Palmer, Shannon, Deal, Allison, Chen, Sheh-Li, Zhu, Anqi, Moll, Stephan

“…Background: Rituximab (RTX) is approved for various malignant hematologic and rheumatologic disorders. A noteworthy side effect, late-onset neutropenia, has…”
Get full text

Mogamulizumab-Associated Rash (MAR) Correlates with Longer Progression Free Survival in Cutaneous T Cell Lymphoma (CTCL) by Hu, Bei, Atrash, Shebli, Cohen, Leah, Barta, Stefan K., Zhang, Yumeng, Sokol, Lubomir, Ayers, Amy, Malpica Castillo, Luis E, Hwang, Steven R, Bennani, N. Nora, Wada, David, Tun, Aung M, Moyo, Tamara K., Ghosh, Nilanjan, Shinohara, Michi M

Get full text

A Retrospective Study on Prephase Therapy Prior to Definitive Multiagent Chemotherapy in Aggressive Lymphomas by Malpica Castillo, Luis E, Galeotti, Jonathan, Grover, Natalie S, Tan, Xianming, Clark, Stephen, Muss, Hyman, Dittus, Christopher

“…Background: Diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) are aggressive lymphomas that evolve rapidly and are fatal if untreated. Most…”
Get full text

Clinical Characteristics and Outcome of Diffuse Large B Cell Lymphoma Among HTLV-1 Carriers in Peru: A Matched Cohort Study by Valcarcel, Bryan, Enriquez, Daniel J, Sandival-Ampuero, Gustavo, Aviles-Perez, Ursula, Haro, Juan C, Alcarraz, Cindy, Quintana, Shirley, Villena, Marco, Dueñas, Daniela, Casavilca, Sandro, Barrionuevo, Carlos, Samanez-Figari, Cesar, Malpica Castillo, Luis E

“…Background: Diffuse large B-cell lymphoma (DLBCL) is the most common variant of non-Hodgkin lymphoma (NHL) accounting for approximately 30% of the NHL cases…”
Get full text

Clinical Features and Outcome of HTLV-1 Carriers Diagnosed with Hodgkin Lymphoma in Peru: A Matched Cohort Study by Sandival-Ampuero, Gustavo, Aviles-Perez, Ursula, Valcarcel, Bryan, Haro, Juan C, Dueñas, Daniela, Barrionuevo, Carlos, Alcarraz, Cindy, Casavilca, Sandro, Villena, Marco, Quintana, Shirley, Samanez-Figari, Cesar, Malpica Castillo, Luis E, Enriquez, Daniel J

“…Background: The human T-cell lymphotropic virus type 1 (HTLV-1) is an oncogenic retrovirus that affects CD4+ T-cell lymphocytes and is the cause for adult…”
Get full text

Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome by Malpica Castillo, Luis E, Campuzano-Zuluaga, German, Toomey, Ngoc L, Pimentel, Agustin, Chapman-Fredricks, Jennifer Rose, Ramos, Juan Carlos

“…Introduction: HTLV-1 related adult T-cell leukemia-lymphoma (ATLL) remains fatal, thus urging development of new therapies. Interferon regulatory factor 4…”
Get full text

CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL by Nair, Ranjit, Ayers, Amy, Nastoupil, Loretta J., Gunther, Jillian R., Fayad, Luis, Fowler, Nathan H., Miranda, Roberto N., Hagemeister, Fredrick B., Lee, Hun Ju, Rodriguez, Maria Alma, Steiner, Raphael, Strati, Paolo, Nieto, Yago, Ramdial, Jeremy L., Chihara, Dai, Wang, Michael L., Malpica Castillo, Luis E, Saini, Neeraj, Jain, Preetesh, Pinnix, Chelsea C., Dabaja, Bouthaina S., Green, Michael R, Flowers, Christopher R., Medeiros, L. Jeffrey, Marques-Piubelli, Mario L., Vega, Francisco, Noorani, Mansoor, Ahmed, Sairah, Westin, Jason, Neelapu, Sattva S., Feng, Lei, Iyer, Swaminathan Padmanabhan

Get full text

Targeting CD30 Expression in Adult T-Cell Leukemia-Lymphoma (ATLL) by Malpica Castillo, Luis E, Campuzano-Zuluaga, German, Toomey, Ngoc L, Pimentel, Agustin, Alencar, Alvaro J., Chapman-Fredricks, Jennifer Rose, Ramos, Juan Carlos

“…▪ Introduction: Adult T-cell leukemia-lymphoma (ATLL) is caused by HTLV-1, and carries a dismal prognosis urging the development of new therapies. CD30…”
Get full text

Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States by Malpica Castillo, Luis E, Pimentel, Agustin, Reis, Isildinha M, Gotuzzo, Eduardo, Lekakis, Lazaros J., Komanduri, Krishna, Harrington, Thomas J., Barber, Glen N., Ramos, Juan Carlos

“…▪ Introduction: Adult T-cell leukemia/lymphoma (ATLL) is an aggressive, peripheral T-cell neoplasm caused by the human T-cell leukemia virus type 1 (HTLV-1)…”
Get full text

Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL) by Malpica Castillo, Luis E, Peña, Camila, Rojas, Christine, León, Pilar, Beltrán, Brady E., Castro, Denisse A., Huerta- Collado, Yesenia M., Quinones, Mimsy, Paredes, Sally Rose, Idrobo, Henry, Perdomo, Ivan, Abello, Virginia, Fiad, Lorena, Otero, Victoria, Torres Viera, Marialejandra, M, Luis Villela, Sotomayor, Eduardo, Castillo, Jorge J, Ramos, Juan Carlos

“…Background: Adult T-cell leukemia/lymphoma (ATLL) is an aggressive, peripheral T-cell neoplasm associated with the human T-cell leukemia virus type 1 (HTLV-1)…”
Get full text